M. Frohn et al. / Tetrahedron Letters 48 (2007) 487–489
489
11. Procedure for the preparation of 4-bromo-2-(cyano-
methyl)benzonitrile (8). Methyl cyanoacetate (22.1 mL,
250 mmol) was slowly added to a suspension of sodium
hydride (10.0 g, 250 mmol, 60% dispersion in mineral oil)
in DMSO (75 mL) at 0 ꢁC. The mixture was stirred for
30 min at room temperature before 4-bromo-2-fluoro-
benzonitrile (25.0 g, 125 mmol) was added as a solution in
DMSO (125 mL) via cannula. The yellow solution was
heated to 90 ꢁC for 2 h, H2O (450 mL) was added, and the
reaction was heated to reflux for 8 h. The mixture was
cooled to 5 ꢁC and 0.1 N HCl (250 mL) was added. After
stirring at 5 ꢁC for 30 min, the resulting precipitate was
filtered, washed with water and dried to afford 4-bromo-2-
As expected, the C(1) bromide could be selectively dis-
placed via SNAr displacement by an amine (microwave
irradiation, entries 1–4)17 or an alkoxide anion (ambient
temperature, entries 5 and 6).18 Next, the 3-amino group
was converted to an acetamide (Ac, entries 1–3, 5 and 6)
or a methyl sulfonamide (Ms, entry 4).5a,b Finally, the
C(6) and C(7) bromides participated in Sonogashira
(entries 2 and 5),19 Heck (entry 4),20 and Suzuki
couplings (entries 1, 3 and 6)21 to give good yields of
substituted isoquinolines.
In conclusion, an efficient synthetic route for the prepa-
ration of 1,6- and 1,7-dibromo-3-aminoisoquinolines in
multigram quantity is presented. As demonstrated in
Scheme 2 and Table 1, these compounds serve as versa-
tile intermediates for the synthesis of multisubstituted 1-
oxo-3-amino- and 1,3-diaminoisoquinoline derivatives
with various substituents at C(6) and C(7). This general
strategy should be applicable for the preparation of
other multisubstituted 3-aminosoquinolines.
1
(cyanomethyl)benzonitrile (25.17 g, 91% yield). H NMR
(400 MHz, CDCl3) d ppm 7.85 (1H, s), 7.65 (1H, d,
J = 8.4 Hz), 7.57 (1H, d, J = 8.2 Hz), 3.99 (2H, s); 13C
NMR (100 MHz, CDCl3) d ppm 135.21, 134.14, 132.39,
132.34, 128.88, 115.84, 115.25, 110.98, 22.35.
12. In one case, small amounts of nitrile hydrolysis were also
observed (10–15% by LC/MS analysis).
13. Preliminary experiments showed that continuous addition
of HBr (g) was required for the reaction to proceed.
14. Minor amounts of nitrile hydrolysis was also observed.
15. Procedure for the preparation of 1,6-dibromoisoquinolin-
3-amine (1). HBr (g) was bubbled through dichloroacetic
acid (100 mL) at 0 ꢁC for 10 min. 4-Bromo-2-(cyano-
methyl)benzonitrile (25.0 g, 113 mmol) was added and the
mixture was stirred at 0 ꢁC for 15 min, warmed to room
temperature and stirred for 1 h. The yellow suspension was
cooled back to 0 ꢁC and Et2O (100 mL) was added slowly.
After stirring at 0 ꢁC for 30 min, the precipitate was filtered,
washed with Et2O (200 mL) and dried. The solid was taken
up in H2O (100 mL) and 1 N NaOH was added until the pH
reached 12. The resulting suspension was stirred for 15 min,
the solid was filtered and then dried. This solid was
suspended in CHCl3 (2 L) and the resulting white precip-
itate was filtered off. The filtrate was concentrated under
vacuum to give 1,6-dibromoisoquinoline-3-amine as a
yellow solid (20.0 g, 59% yield). 1H NMR (400 MHz,
CDCl3) d ppm 7.89 (1H, d, J = 1.8 Hz), 7.78 (1H, d,
J = 9.0 Hz), 7.34 (1H, dd, J = 9.0, 2.0 Hz), 6.58 (1H, s), 6.49
(2H, s); 13C NMR (100 MHz, CDCl3) d ppm 156.23, 142.71,
141.40, 130.03, 126.62, 126.15, 125.16, 119.73, 96.63.
16. All compounds in Table 1 were characterized by 1H
NMR, 13C NMR and high resolution mass spectrometry
(to within 4.0 ppm). All were >95% pure as analyzed by
LC/MS (Phenomenex, MAX RP, 4 lm, 50 · 2.0 mm,
1 mL/min, (A) 0.1% TFA in H2O, (B) 0.1% TFA in
MeCN, 10–100% B in 10 min).
References and notes
1. For an example of anisoquinoline-containing natural
product, see: (a) Zhang, J.-S.; Zhu, D.-Y.; Hong, S.-H.
Phytochemistry 1995, 39, 435–437; For an example of
isoquinolines as acetylcholinesterase inhibitors, see: (b)
Bianchi, D. A.; Hirschmann, G. S.; Theoduloz, C.; Bracca,
A. B. J.; Kaufman, T. S. Bioorg. Med. Chem. Lett. 2005,
15, 2711–2715.
´
2. For a review of isoquinoline chemistry, see: (a) Alvarez,
M.; Joule, J. A. Isoquinolines. In Science of Synthesis;
Black, D., Ed.; Thieme: Germany, 2005; Vol. 15, pp 661–
838; (b) Bressel, U.; Katritzky, A. R.; Lea, J. R. J. Chem.
Soc. (B) 1971, 4–10; (c) Baradarani, M. M.; Joule, J. A. J.
Chem. Soc., Perkin Trans. 1 1980, 72–77.
3. For an example of a 1,3-diaminoisoquinoline derivative
with a C(7) methyl substituent, see: Boyd, G. V.; Lindley,
P. F.; Nicolaou, G. A. J. Chem. Soc., Chem. Commun.
1984, 1105–1107.
4. Johnson, F.; Nasutavicus, W. A. J. Org. Chem. 1962, 27,
3953–3958.
5. (a) Neumeyer, J. L.; Weinhardt, K. K. J. Med. Chem.
1970, 13, 613–616; (b) Neumeyer, J. L.; Weinhardt, K. K.
J. Med. Chem. 1970, 13, 999–1002.
6. Beugelmans, R.; Bois-Choussy, M.; Boudet, B. Tetra-
hedron 1982, 38, 3479–3483.
17. Smith Synthesizerꢂ microwave reactor (Personal Chemis-
try, Upssala, Sweden). See Ref. 5b.
18. (a) Parrish, J. P.; Kastrinsky, D. B.; Hwang, I.; Boger, D.
L. J. Org. Chem. 2003, 68, 8984–8990; (b) Parrish, J. P.;
Kastrinsky, D. B.; Boger, D. L. Org. Lett. 2003, 5, 2577–
2579.
19. Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron
Lett. 1975, 4467–4470.
7. Meisel, R.; Peseke, K.; Reinke, H. J. Carbohydr. Chem.
1998, 17, 1083–1094.
8. Sircar, J. C.; Kostlan, C. R.; Gilbertsen, R. B.; Bennett,
M. K.; Dong, M. K.; Cetenko, W. J. J. Med. Chem. 1992,
35, 1605–1609.
9. (a) Krapcho, A. P.; Lovey, A. J. Tetrahedron Lett. 1973,
957–960; (b) Krapcho, A. P.; Glynn, G. A.; Grenon, B. J.
Tetrahedron Lett. 1967, 215–217.
20. Littke, A. F.; Fu, G. C. J. Am. Chem. Soc. 2001, 123,
6989–7000.
21. Littke, A. F.; Dai, C.; Fu, G. C. J. Am. Chem. Soc. 2000,
122, 4020–4028.
´
´
10. Do¨rnyei, G.; Szantay, C.; Szabo, L. Heterocycles 1994, 39,
449–456.